AfroCentric Investment

AfroCentric is a prominent Black-owned investment holding company established in 2008, headquartered in Roodepoort, Gauteng, South Africa. Listed on the Johannesburg Stock Exchange under the ticker JSE: ACT.JO, the firm has solidified its position as the most diversified healthcare entity in Southern Africa. With a workforce of 5,000-10,000 employees and operations spanning two primary locations, the company maintains a robust operational footprint. AfroCentric focuses on delivering integrated healthcare solutions, leveraging its extensive market presence to drive accessibility and affordability across the region.

The group operates through three core business clusters: Health Administration and Managed Care, Pharmaceutical Solutions, and Corporate Solutions. Key subsidiaries include Medscheme, which serves as South Africa's largest health risk management provider and medical scheme administrator for major clients like Bonitas, Fedhealth, GEMS, and Polmed. Additionally, the company operates Pharmacy Direct, recognized as the nation's largest specialist courier pharmacy. These entities collectively manage more than four million lives, providing comprehensive services ranging from pharmaceutical manufacturing and dental managed care to wellness and occupational health programs.

AfroCentric maintains a Level 1 B-BBEE rating, reflecting its commitment to transformation and economic empowerment. The group operates across four sub-Saharan African countries, with Sanlam Life Insurance Limited holding a controlling stake. Meet AfroCentric's team to understand the leadership driving these strategic initiatives. By integrating advanced technology and specialized healthcare services, the company continues to expand its influence in the Southern African market, ensuring sustainable growth and improved health outcomes for its diverse client base.